ACRS
Price
$2.57
Change
+$0.06 (+2.39%)
Updated
Jan 17 closing price
Capitalization
87.95M
32 days until earnings call
PSNL
Price
$4.89
Change
+$0.11 (+2.30%)
Updated
Jan 17 closing price
Capitalization
75.25M
33 days until earnings call
Ad is loading...

ACRS vs PSNL

Header iconACRS vs PSNL Comparison
Open Charts ACRS vs PSNLBanner chart's image
Aclaris Therapeutics
Price$2.57
Change+$0.06 (+2.39%)
Volume$506.94K
Capitalization87.95M
Personalis
Price$4.89
Change+$0.11 (+2.30%)
Volume$518.35K
Capitalization75.25M
ACRS vs PSNL Comparison Chart
Loading...
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PSNL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACRS vs. PSNL commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRS is a Hold and PSNL is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ACRS: $2.57 vs. PSNL: $4.89)
Brand notoriety: ACRS and PSNL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ACRS: 16% vs. PSNL: 48%
Market capitalization -- ACRS: $87.95M vs. PSNL: $75.25M
ACRS [@Medical Specialties] is valued at $87.95M. PSNL’s [@Medical Specialties] market capitalization is $75.25M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRS’s FA Score shows that 0 FA rating(s) are green whilePSNL’s FA Score has 0 green FA rating(s).

  • ACRS’s FA Score: 0 green, 5 red.
  • PSNL’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACRS and PSNL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRS’s TA Score shows that 1 TA indicator(s) are bullish while PSNL’s TA Score has 3 bullish TA indicator(s).

  • ACRS’s TA Score: 1 bullish, 4 bearish.
  • PSNL’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, PSNL is a better buy in the short-term than ACRS.

Price Growth

ACRS (@Medical Specialties) experienced а +4.05% price change this week, while PSNL (@Medical Specialties) price change was -12.52% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

ACRS is expected to report earnings on May 13, 2025.

PSNL is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACRS($87.9M) has a higher market cap than PSNL($75.3M). ACRS YTD gains are higher at: 3.629 vs. PSNL (-15.398). PSNL has higher annual earnings (EBITDA): -96.81M vs. ACRS (-115.45M). ACRS (119M) and PSNL (114M) have equal amount of cash in the bank . ACRS has less debt than PSNL: ACRS (426K) vs PSNL (47.7M). PSNL has higher revenues than ACRS: PSNL (73.5M) vs ACRS (31.2M).
ACRSPSNLACRS / PSNL
Capitalization87.9M75.3M117%
EBITDA-115.45M-96.81M119%
Gain YTD3.629-15.398-24%
P/E RatioN/AN/A-
Revenue31.2M73.5M42%
Total Cash119M114M104%
Total Debt426K47.7M1%
FUNDAMENTALS RATINGS
ACRS: Fundamental Ratings
ACRS
OUTLOOK RATING
1..100
39
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACRSPSNL
RSI
ODDS (%)
N/A
Bearish Trend 11 days ago
83%
Stochastic
ODDS (%)
N/A
Bearish Trend 11 days ago
85%
Momentum
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
82%
Bearish Trend 11 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
78%
Bullish Trend 11 days ago
83%
Advances
ODDS (%)
Bullish Trend 24 days ago
82%
Bullish Trend 16 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
79%
Aroon
ODDS (%)
Bearish Trend 11 days ago
73%
Bullish Trend 11 days ago
85%
View a ticker or compare two or three
Ad is loading...
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PSNL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADTN10.190.06
+0.59%
ADTRAN Holdings
AXP312.561.08
+0.35%
American Express Company
AE37.41-0.09
-0.24%
Adams Resources & Energy
TARS46.52-0.40
-0.85%
Tarsus Pharmaceuticals
IBP196.00-3.04
-1.53%
Installed Building Products

ACRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRS has been loosely correlated with PLLWF. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRS jumps, then PLLWF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRS
1D Price
Change %
ACRS100%
+2.39%
PLLWF - ACRS
64%
Loosely correlated
N/A
MYNZ - ACRS
40%
Loosely correlated
+3.87%
UFPT - ACRS
39%
Loosely correlated
+1.09%
ANIK - ACRS
34%
Loosely correlated
-0.74%
DXCM - ACRS
33%
Loosely correlated
-0.54%
More

PSNL and

Correlation & Price change

A.I.dvisor tells us that PSNL and XRAY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PSNL and XRAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PSNL
1D Price
Change %
PSNL100%
+2.30%
XRAY - PSNL
31%
Poorly correlated
+1.79%
VTAK - PSNL
30%
Poorly correlated
-1.29%
UTMD - PSNL
27%
Poorly correlated
+0.27%
CDNA - PSNL
27%
Poorly correlated
-2.81%
ACRS - PSNL
26%
Poorly correlated
+2.39%
More